December 2, 2015 — Glades Drugs of Pahokee, Florida has issued a voluntary recall for compounded multivitamin capsules that may contain toxic levels of Vitamin D3 (Cholecalciferol).
There have been several reports of adverse events associated with the vitamins, according to a warning from the FDA.
Vitamin D toxicity is a life-threatening illness that may show few symptoms in early stages. When symptoms do appear, they may include confusion, increased urination, increased thirst, loss of appetite, vomiting, and muscle weakness.
The symptoms are caused by high calcium levels (hypercalcemia), a life-threatening illness with short-term and long-term complications. Patients with liver disease or chronic kidney failure may be especially vulnerable.
Complications of Vitamin D toxicity:
- Intensifying irregular heart rhythms
- Increased effects of some heart drugs
- Kidney failure
- Calcium deposits in blood, soft tissues
- Bone demineralization
The FDA warns consumers not to take the vitamins due to the risk of Vitamin D toxicity:
“Patients suffering adverse effects from high Vitamin D levels (Cholecalciferol) may not initially show symptoms. Therefore, patients who have received these compounded capsules should stop taking this medication and immediately seek medical attention.”
Do I have a Dietary Supplement Lawsuit?
The Schmidt Firm, PLLC is currently accepting dietary supplement induced injury cases in all 50 states. If you or somebody you know has been diagnosed with Vitamin D toxicity after taking multivitamins from Glades Drugs, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Dietary Supplement Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.